These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1531320)

  • 1. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
    Kimoto A; Konno T; Kawaguchi T; Miyauchi Y; Maeda H
    Cancer Res; 1992 Feb; 52(4):1013-7. PubMed ID: 1531320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
    Schmitt DA; Kisanuki K; Kimura S; Oka K; Pollard RB; Maeda H; Suzuki F
    Anticancer Res; 1992; 12(6B):2219-24. PubMed ID: 1295469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
    Oda T; Sato F; Yamamoto H; Akagi M; Maeda H
    Anticancer Res; 1989; 9(2):261-5. PubMed ID: 2526613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
    Numasaki Y; Takahashi K; Masuda E; Nohara C; Maeda H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
    Oda T; Sato F; Maeda H
    J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
    Suzuki F; Okuno Y; Maeda Y; Maeda H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
    Maeda H
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
    Matsumura Y; Maeda H
    Cancer Res; 1986 Dec; 46(12 Pt 1):6387-92. PubMed ID: 2946403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
    Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
    Abe S; Otsuki M
    Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):715-26. PubMed ID: 12678722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
    Yamasaki K; Konno T; Miyauchi Y; Maeda H
    Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.
    Oda T; Yamamoto H; Miki T; Maeda H
    Jpn J Cancer Res; 1989 Apr; 80(4):394-9. PubMed ID: 2526108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.
    Kimura M; Konno T; Miyamoto Y; Kojima Y; Maeda H
    Anticancer Res; 1998; 18(4A):2547-50. PubMed ID: 9703908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
    Oda T; Konno T; Ohtsuka N; Kimura M; Mizumachi R
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2423-8. PubMed ID: 1835341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
    Maeda H
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):169-85. PubMed ID: 11259839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SMANCS/lipiodol].
    Maeda H
    Gan To Kagaku Ryoho; 1994 May; 21(6):907-13. PubMed ID: 8185354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
    VanderPloeg LC; Wolfrom DM; Welsch CW
    Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A preliminary report on the treatment of pleural carcinomatosis with SMANCS].
    Kimura M; Kaneda H; Kume S; Matsushita H; Inoue M; Kai M; Takeuchi H; Uemura K
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1023-5. PubMed ID: 11478133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.